Collaboration: central to our success
Areas of partnering interest
Partnering contacts
Why partner with AstraZeneca?
We partner with academia, governments, peer companies, biotechs, scientific organisations and patient groups to access the best science, stimulate innovation and accelerate delivery of new medicines to target unmet medical need.
From discovery through clinical development, commercialisation and beyond
We’re looking for partners with cutting-edge technologies that can help enhance the quality, effectiveness and productivity of our research and translational capabilities across our therapy areas. We’re also interested in collaborations that leverage key innovations across precision medicine and genomics; artificial intelligence; as well as data and digital technologies, to deliver medicines to patients more efficiently.
Our business development activity takes many forms
Collaborations, in-licensing and acquisitions
with peer companies, biotechs and academia to enhance our portfolio and pipeline across our therapy areas.
Out-licensing and divesting our medicines
它们位于澳门第一赌城在线娱乐的主要治疗领域和成熟品牌之外，可以由合作伙伴或买家更好地部署. 这使澳门第一赌城在线娱乐能够最大限度地发挥资产价值，同时确保患者能够获得这些药物.
Precision medicine collaborations
to help target our innovative medicines to those patients most likely to benefit.
Joint research centres
with leading academic institutes across the globe.
Open Innovation
Our Open Innovation platform offers scientists anywhere access to a large number of optimised compounds, compound libraries, technologies, data and know-how.
Externally sponsored scientific research
外部资助的科学研究可以扩展与产品或相关疾病领域相关的知识. It may help to advance science and contribute to the development of better medicines. Through this platform, we offer access to compounds for clinical research across all phases of drug development, 以及非肿瘤治疗领域的非临床研究(肿瘤学临床前研究请访问澳门在线赌城娱乐开放创新门户网站).
How we evaluate potential collaborations
澳门第一赌城在线娱乐根据“5r”框架对所有项目进行评估，以确保澳门第一赌城在线娱乐抓住最具吸引力的机会, regardless of source. This also enables us to provide consistent, objective feedback to potential partners.
Right target
确定正确的靶标至关重要，因为如果一个分子调节了错误的靶标，它就不能成为一种药物
Right tissue
Making sure the molecule gets to the tissue where it is needed
Right patient
Selecting the patients who will benefit
Right safety
Ensuring safety with minimal side effects
Right commercial
Defining the appropriate commercial value and future viability
Maximising value through successful, long-term partnerships
We are committed to creating strong, 长期伙伴关系有助于加快向有需要的人提供创新和改变生活的药物. 澳门第一赌城在线娱乐也努力确保双方从这种关系中获得最大可能的价值.
Maximising value through successful, long-term partnerships
We are committed to creating strong, 长期伙伴关系有助于加快向有需要的人提供创新和改变生活的药物. 澳门第一赌城在线娱乐也努力确保双方从这种关系中获得最大可能的价值.
Our R&D Alliance Management and Alliance & Integration Management teams are engaged throughout the deal process. Gaining an early understanding of the strategic, 澳门第一赌城在线娱乐与合作伙伴之间的业务和文化契合有助于澳门第一赌城在线娱乐从一开始就尽可能有效地构建伙伴关系治理. It also helps to build trust, transparency and strong relationships at all levels.
Our Alliance Management team members are highly experienced professionals with different backgrounds, which enables us to bring the optimal skill-set to any collaboration. 从澳门第一赌城在线娱乐的联盟管理团队中指派一名专职成员在签约阶段，并在整个合作过程中保持您的主要联系人.
Based on our work across a wide range of complex business and scientific collaborations, we have developed industry-leading processes and tools that ensure smooth and efficient interactions.
In acquisitions, divestments and spinoffs, our Alliance Management teams act as the central hub for key functional areas across the business, ensuring an efficient integration or transition of the products involved.
Articles
Veeva ID: Z4-49876
Date of preparation: November 2022